Wells Fargo Upgrades Five Prime Therapeutics (FPRX) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Five Prime Therapeutics (FPRX) Announces Proposed 5M Share Common Offering
November 11, 2020 4:05 PM ESTFive Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, announced today that it plans to offer and sell, subject to market and other conditions, 5,000,000 shares of its common stock in an... More
Five Prime Therapeutics (FPRX) Halted on LUDP
November 11, 2020 9:48 AM ESTFive Prime Therapeutics (NASDAQ: FPRX) Halted on LUDP
